GEORGE ATALLAH: Open Payments
NPI 1093940694 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,572 in 99 payments from 20 companies in 2025. Trend: 2023 $6,252 · 2024 $5,497 · 2025 $2,572
Food & beverage: $2,572
| Company | Payments | Amount |
|---|---|---|
| Globus Medical, Inc. | 15 | $545 |
| ABBVIE INC. | 17 | $325 |
| PFIZER INC. | 12 | $310 |
| Medtronic, Inc. | 4 | $268 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 14 | $245 |
| Collegium Pharmaceutical, Inc. | 12 | $231 |
| SI-BONE, INC. | 2 | $104 |
| Boston Scientific Corporation | 3 | $100 |
| Averitas Pharma Inc. | 3 | $66 |
| Saluda Medical Americas, Inc. | 2 | $64 |
Products named: Senza, NURTEC ODT, RELISTOR, SYNCHROMEDII, QULIPTA, Belbuca, Vyrsa V1, XTAMPZA.
Industry payments across TX — which companies pay providers there.
